Overview

Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments

Status:
Withdrawn

Trial end date:
2018-07-01

Target enrollment:

Participant gender:

Summary

Bronchiolitis is an extremely common cause of respiratory illness in infants caused by viral infection.This study evaluates whether treatment with nitazoxanide (NTZ) reduces the duration and severity of respiratory symptoms caused by bronchiolitis. Half of the participants will receive NTZ while the other half will receive a placebo.

Phase:

Phase 2

Details

Lead Sponsor:

Telethon Kids Institute

Treatments:

Nitazoxanide